Funds for Healthcare Market Intell Platform Elion

In the US, Elion, an AI-powered research and intelligence platform for healthcare technology, has closed an oversubscribed $9.3m seed round. Funds will be use to accelerate platform development, help launch new products, scale reach across the healthcare tech ecosystem and hire for engineering, research and marketing.

Elion's platform aims to help healthcare organizations make informed decisions about purchase and use of new technology offerings. It combines a structured dataset of thousands of healthcare vendors with deep expertise in the workflows and decision-making dynamics of health systems, to provide guidance on the technologies and the companies behind them. The company says more than 60% of US health systems use its vendor marketplace.

The round was led by existing Elion investor NEA, with participation from new investors Cedars Sinai Health Ventures, TMV, Scrub Capital and Alumni Ventures. Existing backers Max Ventures, AlleyCorp and Floating Point also participated.

Elion CEO and co-founder Bobby Guelich (pictured) comments, 'We're reimagining what a technology research and advisory business looks like in the age of generative AI. The starting point is our vendor marketplace, which has quickly become the go-to resource for health systems and provider organizations trying to make sense of a crowded and fast-changing landscape. The depth of our vendor and product intelligence, combined with our ability to deliver it in a structured, accessible format, is helping healthcare leaders make better, faster decisions.'

Web site: https://elion.health .